174 related articles for article (PubMed ID: 37649039)
21. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
[TBL] [Abstract][Full Text] [Related]
22. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
23. Aspirin use and risk of breast cancer in African American women.
Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR
Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
25. Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
Holmberg D; Gottlieb-Vedi E; Hedberg J; Lindblad M; Mattsson F; Lagergren J
BMC Cancer; 2023 Apr; 23(1):375. PubMed ID: 37098462
[TBL] [Abstract][Full Text] [Related]
26. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
27. The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data.
Kang J; Jeong SM; Shin DW; Cho M; Cho JH; Kim J
J Thorac Oncol; 2021 Jan; 16(1):76-88. PubMed ID: 32950701
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract][Full Text] [Related]
29. Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients.
Choi M; Han J; Yang BR; Jang MJ; Kim M; Lee DW; Kim TY; Im SA; Lee HB; Moon HG; Han W; Noh DY; Lee KH
Cancer Res Treat; 2021 Jan; 53(1):65-76. PubMed ID: 32972040
[TBL] [Abstract][Full Text] [Related]
30. Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.
Scott OW; TinTin S; Harborg S; Kuper-Hommel MJJ; Lawrenson R; Elwood JM
Breast Cancer Res Treat; 2023 May; 199(1):195-206. PubMed ID: 36930345
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
[TBL] [Abstract][Full Text] [Related]
33. Statin use and breast cancer survival: a nationwide cohort study from Finland.
Murtola TJ; Visvanathan K; Artama M; Vainio H; Pukkala E
PLoS One; 2014; 9(10):e110231. PubMed ID: 25329299
[TBL] [Abstract][Full Text] [Related]
34. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
[TBL] [Abstract][Full Text] [Related]
35. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
36. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
37. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies.
Bakierzynska M; Cullinane MC; Redmond HP; Corrigan M
Eur J Surg Oncol; 2023 Oct; 49(10):106940. PubMed ID: 37321932
[TBL] [Abstract][Full Text] [Related]
39. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis.
Antwi SO; Li Z; Mody K; Roberts LR; Patel T
J Clin Gastroenterol; 2020; 54(5):468-476. PubMed ID: 32271517
[TBL] [Abstract][Full Text] [Related]
40. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
